Showing results (421-430 of 1,570) with videos related to

Sort By:
Pageof 157
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|June 17, 1998
Overnight GLP-1 normalizes fasting but not daytime plasma glucose levels in NIDDM patientsB Willms, K Idowu, J J Holst, et al.
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1983
Percutaneous estrogen replacement therapy. Effects on circulating estrogens, gonadotropins and prolactinJ Holst, S Cajander, K Carlström, et al.
Acta Physiologica Scandinavica|March 1, 1981
Secretory effects of gastric inhibitory polypeptide on the isolated perfused porcine pancreasS L Jensen, J J Holst, O V Nielsen, et al.
Metabolism: Clinical and Experimental|January 1, 1994
Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy manA Hvidberg, M T Nielsen, J Hilsted, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1997
Rapid oscillations in plasma glucagon-like peptide-1 (GLP-1) in humans: cholinergic control of GLP-1 secretion via muscarinic receptorsH J Balks, J J Holst, A von zur Mühlen, et al.
The American Journal of Physiology|September 1, 1996
Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pigC F Deacon, L Pridal, L Klarskov, et al.
Digestive Diseases and Sciences|October 1, 1991
Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomyJ Miholic, C Orskov, J J Holst, et al.
The Journal of Clinical Endocrinology and Metabolism|March 3, 2010
Do the actions of glucagon-like peptide-1 on gastric emptying, appetite, and food intake involve release of amylin in humans?Meena Asmar, Michael Bache, Filip K Knop, et al.
Pageof 157